Advertisement

Journal of Assisted Reproduction and Genetics

, Volume 34, Issue 4, pp 451–457 | Cite as

Morbid obesity and pregnancy outcomes after single blastocyst transfer: a retrospective, North American study

  • Miguel Russo
  • Senem Ates
  • Talya Shaulov
  • Michael H. Dahan
Assisted Reproduction Technologies

Abstract

Purpose

Maternal obesity has been shown to affect reproductive function and pregnancy outcomes following in vitro fertilization. More recently, studies have demonstrated lower live birth rates after single blastocyst transfer (SBT) in patients who are overweight or obese. However, the impact of morbid obesity on pregnancy outcomes after SBT has not been well elucidated. The present study aimed to determine whether morbid obesity has a detrimental impact on pregnancy outcomes after SBT in a North American population.

Methods

A retrospective, cohort study including 520 nulliparous and multiparous women undergoing top-quality SBT between August 2010 and March 2014 at a University Health Centre in North America was conducted. Primary outcomes included: miscarriage rate, clinical pregnancy rate, and live birth rate. Subjects were divided into different BMI categories (kg/m2), including <20, 20–24.9, 25.0–29.9, 30–40, and 40 or more.

Results

The miscarriage rate per pregnancy for each group, respectively, was 36, 64, 59, 61, and 50% (p = 0.16); the clinical pregnancy (per patient) rate per group was 36, 52, 38, 26, and 10% (p = 0.009); and the live birth rate (per patient) per group was 35, 50, 38, 26 and 10% (p = 0.03).

Conclusion

Morbid obesity is a strong and independent predictor of poor pregnancy outcomes in patients undergoing top-quality SBT.

Keywords

Single blastocyst transfer Body mass index Live birth rate IVF North America 

Abbreviations

SBT

Single blastocyst transfer

PR

Pregnancy rate

CPR

Clinical pregnancy rate

LBR

Live birth rate

PCOM

Polycystic ovarian morphology

Notes

Contributions

MR: Participated in data extraction and manuscript drafting and revision

TS: Participated in the revision of the manuscript

SA: Participated in the revision of the manuscript

MD: Participated in the data extraction and manuscript drafting and revision

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest..

References

  1. 1.
    WHO. Obesity and overweight. Fact sheet 311; Updated January 2015:1–7. 2015. Retrieved December 6, 2015 from http://www.who.int/mediacentre/factsheets/fs311/en/.
  2. 2.
    NIH National Institute of Diabetes and Digestive and Kidney Diseases. Overweight and obesity statistics. WIN Weight-Control Information Network, 04(4158), 6. 2010. Retrieved December 6, 2015 from http://win.niddk.nih.gov/publications/PDFs/stat904z.pdf.
  3. 3.
    National Heart, Lung and Blood Institute. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: the evidence report. 1998. 98–4083. Retrieved on December 6, 2015 from http://www.nhlbi.nih.gov/health-pro/guidelines/archive/clinical-guidelines-obesity-adults-evidence-report.
  4. 4.
    The Practice Committee of the American Society of Reproductive Medicine. Obesity and reproduction: a committee opinion. Fertil Steril. 2015;104(5):1116–26. doi: 10.1016/j.fertnstert.2015.08.018.CrossRefGoogle Scholar
  5. 5.
    Fedorcsak P, Dale PO, Storeng R, Ertzeid G, Bjercke S, Oldereid N, et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod. 2004;19:2523–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Wang JX, Davies M, Norman RJ. Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. BMJ. 2000;321:1320–1.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Robker RL. Evidence that obesity alters the quality of oocytes and embryos. Pathophysiology. 2008;15:115–21.CrossRefPubMedGoogle Scholar
  8. 8.
    Rittenberg V, Seshadri S, Sunkara S, Sobaleva S, Oteng-Ntim, El-Toukhy T. Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reprod Med Online. 2011;23(4):421–39.CrossRefGoogle Scholar
  9. 9.
    Provost MP, Acharya KS, Acharya CR, Yeh JS, Steward RG, Eaton JL, et al. Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008-2010 Society for Assisted Reproductive Technology registry. Fertil Steril. 2015; 105:663–669Google Scholar
  10. 10.
    Thurin A, Hausken J, Hillensjö T, Jablonowska B, Pinborg A, Strandell A, et al. Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization. 2009;2392–402. doi: 10.1056/NEJMoa041032.
  11. 11.
    Stillman RJ, Richter KS, Banks NK, Graham JR. Elective single embryo transfer: a 6-year progressive implementation of 784 single blastocyst transfers and the influence of payment method on patient choice. Fertil Steril. 2009;92:1895–906.CrossRefPubMedGoogle Scholar
  12. 12.
    Mullin CM, Fino ME, Talebian S, Krey LC, Licciardi F, Grifo J. Comparison of pregnancy outcomes in elective single blastocyst transfer versus double blastocyst transfer stratified by age. Fertil Steril. 2010;93:1837–43.CrossRefPubMedGoogle Scholar
  13. 13.
    Rittenberg V, Sobaleva S, Ahmad A, Oteng-Ntim E, Bolton V, Khalaf Y, et al. Influence of BMI on risk of miscarriage after single blastocyst transfer. Hum Reprod. 2011;26(10):2642–50.CrossRefPubMedGoogle Scholar
  14. 14.
    Dessolle L, Fréour T, Ravel C, Jean M, Colombel A, Daraï E, et al. Predictive factors of healthy term birth after single blastocyst transfer. Hum Reprod. 2011;26(5):1220–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Sifer C, Herbemont C, Adda-Herzog E, Sermondade N, Dupont C, Cedrin-Durnerin I, et al. Clinical predictive criteria associated with live birth following elective single embryo transfer. EJOG. 2014;181:229–32.Google Scholar
  16. 16.
    Dahan MH, Agdi M, Shehata F, Son W, Tan SL. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis. Eur J Obstet Gynecol Reprod Biol. 2014;172:70–3.CrossRefPubMedGoogle Scholar
  17. 17.
    Gardner DK, Schoolcraft WB. In vitro culture of human blastocyst. In: Jansen R, Mortimer D, editors. Towards reproductive certainty: infertility and genetics beyond 1999. Carnforth: Parthenon Press; 1999. p. 378–88.Google Scholar
  18. 18.
    Baker VL, Jones CE, Cometti B, Hoehler F, Salle B, Urbancsek J, et al. Factors affecting success rates in two concurrent clinical IVF trials: an examination of potential explanations for the difference in pregnancy rates between the United States and Europe. Fertil Steril. 2010;94(4):1287–91.CrossRefPubMedGoogle Scholar
  19. 19.
    Fedorcsak P, Storeng R, Dale PO, Tanbo T, Abyholm T. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand. 2000;79:43–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Metwally M, Cutting R, Tipton A, Skull J, Ledger WL, Li TC. Effect of increased body mass index on oocyte and embryo quality in IVF patients. Reprod Biomed Online. 2007;15:532–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Wittemer C, Ohl J, Bailly M, Bettahar-Lebugle K, Nisand I. Does body mass index of infertile women have an impact on IVF procedure and outcome? J Assist Reprod Genet. 2000;17:547–52.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Vilarino F, Christofolini D, Rodrigues D, de Souza A, Christofolini J, Bianco B, et al. Body mass index and fertility: is there a correlation with human reproduction outcomes? Gynecol Endocrinol. 2011;27:232–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Bellver J, Rossal L, Bosch E, Zúñiga A, Corona J, Melendez F. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril. 2003;79(5):1136–40.CrossRefPubMedGoogle Scholar
  24. 24.
    Tian L, Shen H, Lu Q, Norman R, Wang J. Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment. JCEM. 2007;92(4):1430–3.PubMedGoogle Scholar
  25. 25.
    Gonzalez R, Caballero-Campo P, Jasper M, Mercader A, Devoto L, Pellicer A, et al. Leptin and leptin receptor are expressed in the human endometrium and endometrial leptin secretion is regulated by the human blastocyst. JCEM. 2000;85(12):4883–8.PubMedGoogle Scholar
  26. 26.
    Luke B, Brown MB, Missmer SA, Bukulmez O, Leach R, Stern JE. The effect of increasing obesity on the response to and outcome of assisted reproductive technology: a national study. Fertil Steril. 2011;96(4):820–5. doi: 10.1016/j.fertnstert.2011.07.1100.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  1. 1.Department of Obstetrics and Gynaecology, The Ottawa HospitalUniversity of OttawaOttawaCanada
  2. 2.Division of Reproductive Endocrinology and InfertilityMcGill University, MUHC Reproductive CentreMontrealCanada

Personalised recommendations